Narodowy Bank Polski:企業の戦略的SWOT分析

◆英語タイトル:Narodowy Bank Polski - Strategic SWOT Analysis Review
◆商品コード:GDFS69264SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Narodowy Bank Polski – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Narodowy Bank Polski (NBP) contains monetary policy, macroprudential supervision, payment system, financial system, and currency issuance. The monetary policy comprises policy formation, implication, and monitoring and inflation, and GDP projection. Macro-Prudential supervision consists of a counter cycle buffer and macro-prudential instruments. The payment system contains monitoring payment systems, payment regulations, and card charges reduction. The financial system comprises financial stability reports, financial systematic development, survey, foreign exchange and over-the-counter derivatives market turnover, co-operation with the European Union, and research papers. The bank regulates central bank instruments, exchange rates, monetary and financial statistics, inflation expectations and forecasts, and macro-economic data. Currency issuance includes banknote issuing, collecting banknotes, and coin issuing. It also offers support to commercial and retail banks of the country and central and state governments. NBP is headquartered in Warsaw, Poland.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
Section 1 – About the Company
Narodowy Bank Polski – Key Facts
Narodowy Bank Polski – Key Employees
Narodowy Bank Polski – Major Products and Services
Narodowy Bank Polski – History
Narodowy Bank Polski – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Narodowy Bank Polski – Business Description
Narodowy Bank Polski – SWOT Analysis
SWOT Analysis – Overview
Narodowy Bank Polski – Strengths
Narodowy Bank Polski – Weaknesses
Narodowy Bank Polski – Opportunities
Narodowy Bank Polski – Threats
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Narodowy Bank Polski, Key Facts
Narodowy Bank Polski, Key Employees
Narodowy Bank Polski, Major Products and Services
Narodowy Bank Polski, History
Narodowy Bank Polski, Other Locations

★海外企業調査レポート[Narodowy Bank Polski:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China National Petroleum Corp:電力:M&Aディール及び事業提携情報
    Summary China National Petroleum Corp (CNPC) is an integrated energy company. Its businesses cover oil and gas exploration and development, refining and chemicals, marketing and trading, pipeline transmission and stockpiling, technical services, engineering construction, equipment manufacturing, fin …
  • Cardiovascular Systems Inc (CSII):製品パイプライン分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessorie …
  • Fubon Financial Holding Co Ltd:戦略・SWOT・企業財務分析
    Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CFF GmbH & Co KG :企業の戦略・SWOT・財務情報
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Clementia Pharmaceuticals Inc (CMTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Clementia Pharmaceuticals Inc (Clementia) is a clinical stage biopharmaceutical company that focuses on the development of treatments for rare bone disorders and other diseases. Its lead product candidate Palovarotene is used for the treatment of fibrodysplasia ossificans progressiva (FOP), …
  • Cornerstone Capital Resources Inc (CGP):企業の財務・戦略的SWOT分析
    Summary Cornerstone Capital Resources Inc (Cornerstone) operates as a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration, management, operations, production, mining, and development of rare earth elements, nickel, uranium …
  • NeuStar, Inc.:企業の戦略的SWOT分析
    NeuStar, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • FitLife Brands Inc:企業の戦略・SWOT・財務情報
    FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • US Physical Therapy Inc (USPH):企業の財務・戦略的SWOT分析
    US Physical Therapy Inc (USPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務分析
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Carrabba’s Italian Grill, Inc.:企業の戦略・SWOT・財務情報
    Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Aequus Pharmaceuticals Inc (AQS):医療機器:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Inform Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • Enzo Clinical Labs Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc, is a medical laboratory that provides testing services. The company develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets, among others. It provides …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Plenus Company Limited:企業の戦略・SWOT・財務情報
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • LKQ Corporation:企業の戦略・SWOT・財務情報
    LKQ Corporation - Strategy, SWOT and Corporate Finance Report Summary LKQ Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Camellia PLC (CAM):企業の財務・戦略的SWOT分析
    Summary Camellia Plc (Camellia) is a provider of business processing services. The company operates business through agriculture, food service, engineering and investment sectors. Camellia’s agriculture business division offers products such as rubber, maize, citrus, soya and barley, wine, pineapple …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆